SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

Galectin Therapeutics Q1 EPS $(0.060) Up From $(0.200) YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.060) per share. This is a 70 percent increase over losses of $(0.200) per share from the same period last year.

Benzinga · 05/11/2020 11:53

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.060) per share. This is a 70 percent increase over losses of $(0.200) per share from the same period last year.